Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus

NCT04100473 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Inhaled Human Insulin
DRUG: Insulin Lispro (Humalog U-100)

Sponsor

Dance Biopharm Inc.

Collaborators

[object Object]